Literature DB >> 28303284

[Generalized circumscribed scleroderma with blisters].

G Wagner1, V Meyer2, M M Sachse2.   

Abstract

The patient suffered from a 20-year course of generalized circumscribed scleroderma and presented with blisters in circumscribed areas of the affected skin. The development of subepidermal blisters has been described in all clinical forms of circumscribed scleroderma. Aetiology and pathogenesis of blister formation have not yet been clarified. An obstruction of the lymphatic vessels due to the present sclerosis is favoured. Treatment of bullous circumscribed scleroderma is considered to be difficult. Oral steroids, methotrexate, hydroxychloroquine and PUVA methods have been used with varying success.

Entities:  

Keywords:  Bullous morphea; Herpes zoster; Hydroxychloroquine; Obstructed lymphatic vessels; Subepidermal blistering

Mesh:

Substances:

Year:  2017        PMID: 28303284     DOI: 10.1007/s00105-017-3962-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  19 in total

1.  Scleroderma with bullous lesions. Report of a case and review of the literature.

Authors:  J GARB; C F SIMS
Journal:  Dermatologica       Date:  1959-12

2.  High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: toward a better understanding of the spectrum of morphea.

Authors:  Virginie Lutz; Camille Francès; Didier Bessis; Anne Cosnes; Nicolas Kluger; Julien Godet; Erik Sauleau; Dan Lipsker
Journal:  Arch Dermatol       Date:  2011-10-17

3.  Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center.

Authors:  Alexander Kreuter; Jana Wischnewski; Sarah Terras; Peter Altmeyer; Markus Stücker; Thilo Gambichler
Journal:  J Am Acad Dermatol       Date:  2012-04-24       Impact factor: 11.527

Review 4.  Chronic myelogenous leukemia and porphyria cutanea tarda in a patient with limited systemic sclerosis.

Authors:  M D Wooten; J W Scott; A M Miller; E Boh
Journal:  South Med J       Date:  1998-05       Impact factor: 0.954

5.  Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases.

Authors:  M S Daoud; W P Su; K M Leiferman; C Perniciaro
Journal:  J Am Acad Dermatol       Date:  1994-06       Impact factor: 11.527

6.  Bullous morphea: a distinct entity?

Authors:  A Trattner; M David; M Sandbank
Journal:  Am J Dermatopathol       Date:  1994-08       Impact factor: 1.533

7.  Coexistence of localized bullous pemphigoid, morphea, and subcorneal pustulosis.

Authors:  J E Bernstein; M Medenica; K Soltani
Journal:  Arch Dermatol       Date:  1981-11

Review 8.  Bullous lesions in scleroderma.

Authors:  Adrienne Rencic; Supriya Goyal; Mona Mofid; Frederick Wigley; H Carlos Nousari
Journal:  Int J Dermatol       Date:  2002-06       Impact factor: 2.736

9.  Bullous scleroderma.

Authors:  D R Synkowski; W C Lobitz; T T Provost
Journal:  Arch Dermatol       Date:  1981-03

Review 10.  Localized scleroderma: clinical spectrum and therapeutic update.

Authors:  Mariana Figueiroa Careta; Ricardo Romiti
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.